Li, F., Opat, S., Li, D., Zhou, K., Liu, P., Yang, W., Cheah, C., Wang, T., Yang, Y., Li, C., Jing, H., Ngu, H., Chen, L., Deng, T., Xie, F., Shah, N., Xu, Z., Delarue, R., Li, J. (2025). Preliminary results from a phase 1/1b first-in-human study of BGB-21447, a next-generation BCL2 inhibitor, in patients with B-cell non-Hodgkin lymphoma. Blood. https://doi.org/10.1182/blood-2025-1910